Antenatal and postpartum major depressive episode (MDE) according to Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-V) is defined as either daily sustained sad mood or lack of enjoyment or desire for a minimum two weeks plus four associated manifestations (only three if the two major symptoms are present) that start throughout pregnancy or during the first 4 weeks postpartum respectively: 1) Unintentional notable slimming up or down; 2) Sleepiness or sleeplessness; 3) Tiredness sensation; 4) Guilty or futility sensation; 5) Declined concentration capacity; 6) Frequent suicidal thoughts; 7) Psychomotor excitation or delay. Perinatal depression carries vital and adverse consequences on mother’s psychosocial aspects of life, pregnancy and delivery outcomes, her interrelations specifically with the new born with poorer overall health and influences negatively on offspring from the intrauterine life passing by complicated delivery experiencing hard unstable childhood reaching unhealthy adolescence and adulthood. These negative consequences necessitate a great attention for prevention, screening and prompt treatment for antenatal and postnatal depression to prevent such disastrous effects.

The pharmaceutical industry is undergoing a profound transformation driven by advancements in Information Technology (IT), with Enterprise Resource Planning (ERP) systems playing a pivotal role in reshaping operations. These systems offer integrated solutions that streamline key business processes, such as production, inventory management, supply chain optimization, regulatory compliance, and data integration, contributing significantly to operational efficiency and organizational agility. This paper explores the evolution and impact of ERP systems within the pharmaceutical sector, highlighting their contributions to overcoming the industry’s inherent challenges, including complex regulatory requirements, the need for accurate and real-time data, and the demand for supply chain resilience. The integration of cloud-based ERP solutions, the incorporation of emerging technologies like Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT), and enhanced data analytics capabilities have revolutionized pharmaceutical IT. These advancements not only reduce operational costs, improve forecasting accuracy, and enhance collaboration but also ensure compliance with stringent global regulations, such as Good Manufacturing Practices (GMP) and FDA guidelines. Moreover, ERP systems have been instrumental in managing the pharmaceutical supply chain, ensuring product traceability, and improving inventory control and order fulfillment processes. This manuscript examines how ERP systems enable pharmaceutical companies to maintain high standards of product quality, improve decision-making, and ensure the safety and efficacy of drugs through robust tracking and auditing mechanisms. A case study of a pharmaceutical company that implemented an ERP system demonstrates the tangible benefits, including increased operational efficiency, improved compliance rates, and enhanced customer satisfaction. However, despite the clear advantages, challenges such as customization complexities, data integration issues, and resistance to change remain. As the pharmaceutical industry continues to evolve, ERP systems will remain a cornerstone of digital transformation, facilitating smarter decision-making, better resource management, and enhanced collaboration across global operations. This paper also identifies future trends, including the potential of AI and blockchain technologies in further strengthening ERP systems and transforming the pharmaceutical landscape.

The pharmaceutical supply chain has become increasingly complex and vulnerable to various risks, including counterfeit drugs, diversion, and fraud. As these challenges threaten patient safety and the integrity of global healthcare systems, serialization has emerged as a pivotal innovation in pharmaceutical logistics and regulatory compliance. Serialization involves assigning unique identifiers to individual drug packages, enabling precise tracking and authentication at every stage of the supply chain. This process provides unprecedented transparency, enhances product security, and facilitates real-time monitoring of pharmaceutical products as they move from manufacturers to end consumers. Despite its potential to revolutionize pharmaceutical traceability, the integration of serialization technologies faces numerous obstacles. These include high implementation costs, regulatory inconsistencies across regions, and the technological challenges of managing vast amounts of data. Moreover, the complex, multi-tiered nature of the global supply chain introduces additional risks related to data integrity, cybersecurity, and interoperability between systems. As pharmaceutical companies seek to navigate these challenges, innovations in serialization technology—such as blockchain, artificial intelligence (AI), the Internet of Things (IoT), and radio frequency identification (RFID)—are providing promising solutions to enhance efficiency, reduce fraud, and increase visibility. This manuscript explores both the innovative advancements and the key challenges associated with the integration of serialization in the pharmaceutical supply chain. It delves into the evolving regulatory landscape, highlighting the need for global harmonization of serialization standards, and examines the impact of serialization on securing pharmaceutical distribution networks. Additionally, the paper emphasizes the importance of collaboration among manufacturers, technology providers, and regulatory bodies in overcoming implementation barriers and realizing the full potential of serialization. As the pharmaceutical industry moves towards a more interconnected and data-driven future, serialization promises to play a central role in shaping the next generation of drug safety and supply chain management. By addressing the hurdles to adoption and leveraging emerging technologies, the pharmaceutical sector can create a more secure, transparent, and efficient supply chain that better serves public health and fosters greater trust among consumers and healthcare professionals alike.

Among the most significant systems that organizations of all stripes, whether public or private, use is the Enterprise Resource Planning (ERP) system. Due in large part to the rapid growth of Internet services and the growing reliance on the infrastructure of Cloud service providers, ERP design has advanced, and numerous types of Internet-service-dependent ERP systems have emerged. In addition to the traditional ERP system, the most significant ERP types are Web-based ERP and Cloud ERP. As a result, ERP system vendors and designers, including Oracle and SAP, are relying on cloud-based ERP system design, and offering the ERP system as a service for monthly and annual subscription, where the system is external to the organization and does not need to exist within the organization.

The SAP HANA Application to handle operational workloads that are consistent with transactions while also supporting intricate business analytics operations. Technically speaking, the SAP HANA database is made up of several data processing engines that work together with a distributed query processing environment to provide the entire range of data processing capabilities. This includes graph and text processing for managing semi-structured and unstructured data within the same system, as well as classical relational data that supports both row- and column-oriented physical representations in a hybrid engine. The next-generation SAP Business Suite program designed specifically for the SAP HANA Platform is called SAP S/4HANA. The key features of SAP S/4HANA are an intuitive, contemporary user interface (SAP Fiori); planning and simulation options in many conventional transactions; simplification of business processes; significantly improved transaction efficiency; faster analytics.

Our lives are becoming more and more digital, and this has an impact on how we work, study, communicate, and interact. Businesses are currently digitally altering their information systems, procedures, culture, and strategy. Existing businesses and economies are severely disrupted by the digital revolution. The Internet of Things, microservices, and mobile services are examples of IT systems with numerous, dispersed, and very small structures that are made possible by digitization. Utilizing the possibilities of cloud computing, mobile systems, big data and analytics, services computing, Internet of Things, collaborative networks, and decision support, numerous new business prospects have emerged throughout the years. The logical basis for robust and self-optimizing run-time environments for intelligent business services and adaptable distributed information systems with service-oriented enterprise architectures comes from biological metaphors of living, dynamic ecosystems. This has a significant effect on how digital services and products are designed from a value- and service-oriented perspective. The evolution of enterprise architectures and the shift from a closed-world modeling environment to a more flexible open-world composition establish the dynamic framework for highly distributed and adaptive systems, which are crucial for enabling the digital transformation. This study examines how enterprise architecture has changed over time, taking into account newly established, value-based relationships between digital business models, digital strategies, and enhanced enterprise architecture.

Regardless of their traditional ERP Systems, it is essential for every business to acquire a universal advantage in the contemporary international market. When everything is considered, end users in these kinds of businesses have to deal with poorly designed interfaces and unusable technologies. Despite the claims of significant benefits from using S4 Hana cloud ERP software, the possibility of achieving maximum productivity is not fully utilized. One of the causes of this reality is the underfunding of ergonomic measures and the newest technologies. Through the design of S4 Hana cloud ERP software applications, we will demonstrate how important and highly recommended ergonomic research is in order to minimize the financial and human costs that enterprises are currently facing.

Both crucial success and critical failure factors are included in the current review work. The method relies on creating surveys to collect optional data. It describes the terms that are used to obtain research papers on the ERP deployment in Enterprise Business from databases and scholarly research. In order to enhance the quality of papers, it also includes the consideration and restriction criteria. At that time, a thorough audit of the available papers is conducted to determine the impact of ERP use in Enterprise Business. Important elements are found that determine whether ERP deployments are successful or unsuccessful, as well as how they actually affect Enterprise Business (insert actual success and failure variables here aside from impact). The time span during which research publications have been evaluated limits the scope of the study presented in this paper. One implicit drawback is that it only considers the state of the art in the field of study, without taking into account an empirical investigation. Nevertheless, its findings may prove advantageous, and the directions for future research aid in expanding the field of study. This work advances the body of knowledge regarding the potential benefits and drawbacks of ERP adoption for small and medium-sized enterprises. It uses a secondary data collection strategy to identify important success factors, important failure factors, and their impact. The insights will assist Enterprise Business, Enterprise Business' stakeholders, and ERP service providers in understanding the causes of success or failure and in taking the appropriate action.

The review article presents how emerging technologies improves the business enterprise applications for process management. The paper considers certain technologies of enterprise applications and justifies the updated methodological and analytical tools for assessing, selecting, and regulating business processes in a single enterprise resource planning (ERP) system. Information technology must be used to identify products, track their movement into and out of the warehouse using code scanning technology, and streamline the product management procedure. To increase the dependability of management techniques, guarantee that the business operates flawlessly, and maintain a regular management mode, the process management form should be implemented in the enterprise management process. The implementation of digital information technology is essential for achieving effective corporate management. In addition to providing ideal operational circumstances for businesses, it is essential to analyse information technology and manage businesses economically. The foundation for implementing the enterprise applications method strategy is the creation of a process management system and an in-depth, methodical review of the enterprise as a collection of processes. Process-oriented enterprise applications should be the foundation of contemporary novel technologies for modelling business processes. It shares a tight relationship with workflow management systems (WFM), enterprise resource planning (ERP), and total quality management (TQM).